Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2U19AI057229 | U.S. NIH Grant/Contract | View source | |
| 1U54CA260517-01 | U.S. NIH Grant/Contract | View source | |
| 1R21ES033049-01 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | NIH |
| National Cancer Institute (NCI) | NIH |
| National Institute of Environmental Health Sciences (NIEHS) | NIH |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COVID-19 | Participants diagnosed with COVID-19 |
| |
| Controls | Participants not diagnosed with COVID-19 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| There is no intervention | Other | There is no intervention |
|
| Measure | Description | Time Frame |
|---|---|---|
| Testing Immunity to SARS-CoV-2 over time | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Testing the virus over time | 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adults (18 years and older) and children diagnosed and not diagnosed (controls) with COVID-19
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kari Nadeau, MD, PhD | Stanford University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford Health Care - ValleyCare | Pleasanton | California | 94588 | United States | ||
| Stanford University, Hospital, and Clinics |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35801588 | Derived | Jia X, Cao S, Lee AS, Manohar M, Sindher SB, Ahuja N, Artandi M, Blish CA, Blomkalns AL, Chang I, Collins WJ, Desai M, Din HN, Do E, Fernandes A, Geng LN, Rosenberg-Hasson Y, Mahoney MR, Glascock AL, Chan LY, Fong SY; CLIAHUB Consortium; Chan Zuckerberg Biohub; Phelps M, Raeber O; Stanford COVID-19 Biobank Study Group; Purington N, Roltgen K, Rogers AJ, Snow T, Wang TT, Solis D, Vaughan L, Verghese M, Maecker H, Wittman R, Puri R, Kistler A, Yang S, Boyd SD, Pinsky BA, Chinthrajah S, Nadeau KC. Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome. JCI Insight. 2022 Jul 8;7(13):e156713. doi: 10.1172/jci.insight.156713. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018352 | Coronavirus Infections |
| ID | Term |
|---|---|
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood sample and optional nasopharyngeal swab, cheek swab with saliva collection, nasal swab, stool sample, blood microsample, and endotracheal aspirate (sputum samples)
| Stanford |
| California |
| 94305 |
| United States |
| D007239 |
| Infections |